Mirae Asset Global Investments Co., Ltd. Blueprint Medicines Corp Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 34,532 shares of BPMC stock, worth $3.97 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
34,532
Previous 37,414
7.7%
Holding current value
$3.97 Million
Previous $3.45 Million
5.1%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding BPMC
# of Institutions
316Shares Held
60.6MCall Options Held
634KPut Options Held
691K-
Black Rock Inc. New York, NY6.45MShares$741 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$725 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.25MShares$719 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$480 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.5MShares$287 Million6.2% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.87B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...